4//SEC Filing
Forman Stephen J. 4
Accession 0001493152-21-001036
CIK 0001335105other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 2:29 PM ET
Size
11.5 KB
Accession
0001493152-21-001036
Insider Transaction Report
Form 4
Forman Stephen J.
Director
Transactions
- Award
Options to Purchase Common Stock
2021-01-06+50,000→ 50,000 totalExercise: $3.21From: 2021-01-06Exp: 2026-01-06→ Common (50,000 underlying)
Holdings
- 8,333
Options to Purchase Common Stock
Exercise: $6.60From: 2019-05-22Exp: 2024-05-22→ Common (8,333 underlying) - 33,333
Options to Purchase Common Stock
Exercise: $0.96From: 2016-05-13Exp: 2021-05-13→ Common (33,333 underlying) - 8,333
Options to Purchase Common Stock
Exercise: $0.90From: 2017-10-16Exp: 2022-10-16→ Common (8,333 underlying) - 21,053(indirect: By Trust)
Warrants to Purchase Common Stock
Exercise: $5.70From: 2018-12-07Exp: 2022-12-07→ Common (21,053 underlying) - 16,667(indirect: By Trust)
Warrants to Purchase Common Stock
Exercise: $6.00From: 2018-12-07Exp: 2022-12-07→ Common (16,667 underlying)
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0001676461
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 2:29 PM ET
- Size
- 11.5 KB